IT9048456A0 - Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus. - Google Patents

Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.

Info

Publication number
IT9048456A0
IT9048456A0 IT9048456A IT4845690A IT9048456A0 IT 9048456 A0 IT9048456 A0 IT 9048456A0 IT 9048456 A IT9048456 A IT 9048456A IT 4845690 A IT4845690 A IT 4845690A IT 9048456 A0 IT9048456 A0 IT 9048456A0
Authority
IT
Italy
Prior art keywords
procedure
production
well
carboxylic acids
active agents
Prior art date
Application number
IT9048456A
Other languages
English (en)
Other versions
IT9048456A1 (it
IT1246328B (it
Inventor
Joachim Kalden
Bernhard Fleckenstein
Andreas Baur
Thomas Harrer
Original Assignee
Asta Pharma Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Asta Pharma Ag filed Critical Asta Pharma Ag
Publication of IT9048456A0 publication Critical patent/IT9048456A0/it
Publication of IT9048456A1 publication Critical patent/IT9048456A1/it
Application granted granted Critical
Publication of IT1246328B publication Critical patent/IT1246328B/it

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
    • A61K31/385—Heterocyclic compounds having sulfur as a ring hetero atom having two or more sulfur atoms in the same ring
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/14—Antivirals for RNA viruses

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Virology (AREA)
  • Oncology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IT04845690A 1989-11-09 1990-11-08 Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus. IT1246328B (it)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3937325 1989-11-09
DE4015728 1990-05-16

Publications (3)

Publication Number Publication Date
IT9048456A0 true IT9048456A0 (it) 1990-11-08
IT9048456A1 IT9048456A1 (it) 1992-05-08
IT1246328B IT1246328B (it) 1994-11-17

Family

ID=25886910

Family Applications (1)

Application Number Title Priority Date Filing Date
IT04845690A IT1246328B (it) 1989-11-09 1990-11-08 Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.

Country Status (19)

Country Link
US (1) US5334612A (it)
EP (1) EP0427246B1 (it)
JP (1) JPH03188021A (it)
AT (2) ATE126053T1 (it)
BE (2) BE1003834A5 (it)
CA (1) CA2029599C (it)
CH (1) CH684054A5 (it)
DE (3) DE59009497D1 (it)
DK (3) DK173585B1 (it)
ES (2) ES2076279T3 (it)
FR (1) FR2653997B1 (it)
GB (1) GB2239797B (it)
GR (3) GR1000918B (it)
IE (1) IE67874B1 (it)
IT (1) IT1246328B (it)
LU (1) LU87834A1 (it)
NL (1) NL9002438A (it)
PT (1) PT95827B (it)
SE (1) SE508601C2 (it)

Families Citing this family (49)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK0530446T3 (da) * 1991-07-05 1998-09-23 Asta Medica Ag Anvendelse af svovlholdige carboxylsyrer til bekæmpelse af pathophysiologisk betingede exitationsforstyrrelser
DE4320117A1 (de) * 1992-01-18 1994-12-22 Margarethe Rabien Kombinatinspräparate
DE4201196C2 (de) * 1992-01-18 1997-05-15 Rabien Margarethe Arzneimittel zur Behandlung der Polyneuropathie
EP0560092B1 (de) * 1992-03-11 1997-12-03 ASTA Medica Aktiengesellschaft Tabletten, Granulate und Pellets mit hohem Gehalt an Wirkstoffen für hochkonzentrierte, feste Darreichungsformen
US5569670A (en) * 1992-06-05 1996-10-29 Asta Medica Aktiengesellschaft Combination medications containing alpha-lipoic acid and related
DE4218572A1 (de) * 1992-06-05 1993-12-09 Asta Medica Ag Synergistische Kombination von Arzneimitteln enthaltend als Wirkstoff alpha-Liponsäure, Dihydroliponsäure, deren Metaboliten sowie die oxidierten und reduzierten Enantiomere der alpha-Liponsäure wie die R-alpha-Liponsäure oder S-alpha-Liponsäure sowie Metaboliten der alpha-Liponsäure mit den Vitaminen A, B1-6, B12, C und E
DE9213914U1 (de) * 1992-10-15 1992-12-03 Asta Medica AG, 6000 Frankfurt Ampulle und Infusionslösung von Thioctsäure in Form der wasserlöslichen Salze der Thioctsäure
WO1994022438A1 (en) * 1993-03-26 1994-10-13 Constantin Romulus Dinu Pharmaceutical composition for the treatment of certain viruses and autoimmune diseases and the procedure of its preparation
DE4345199C2 (de) * 1993-05-22 1995-10-12 Asta Medica Ag Verwendung von Dihydroliponsäure zur Unterdrückung von Unverträglichkeitsreaktionen im Grenzbereich von Implantaten mit lebendem Körpergewebe
DE4317173C2 (de) * 1993-05-22 1995-06-14 Asta Medica Ag Verwendung von Dihydroliponsäure als Ophthalmologicum
DE4338508A1 (de) * 1993-11-11 1995-05-18 Asta Medica Ag Arzneimittelzubereitungen enthaltend Thioctsäure oder Dihydroliponsäure in Form von Einschlußverbindungen mit Cyclodextrinen oder Cyclodextrinderivaten und in Form von Granulaten, Kau- oder Brausetabletten
US5463093A (en) * 1993-11-26 1995-10-31 Garnett; Merrill Palladium complexes and methods for using same in the treatment of tumors or Psoriasis
DE4433764A1 (de) 1994-09-22 1996-03-28 Asta Medica Ag Darreichungsformen enthaltend alpha-Liponsäure, feste Salze von R-Thioctsäure mit verbesserter Freisetzung und Bioverfügbarkeit
DE4439480C1 (de) * 1994-11-08 1996-06-05 Asta Medica Ag Verwendung von D,L- alpha-Liponsäure und/oder ihren Enantiomeren, und/oder ihren Derivaten als Zusatz bei Erythrozyten-Flüssigkonserven für homologe und autologe Erythrozyten-Konzentrate und als Zusatz bei Erythrozyten-Kryokonserven für homologe und autologe Erythrozytenkonzentrate
US6046228A (en) * 1996-07-05 2000-04-04 The United States Of America As Represented By The Department Of Health And Human Services Anti-viral pharmaceutical compositions containing saturated 1,2-dithiaheterocyclic compounds and uses thereof
WO1998023606A1 (en) * 1996-11-27 1998-06-04 Fuji Kagaku Kogyo Kabushiki Kaisha Cyclic dithio derivatives, remedies for diabetic kidney diseases, hypoglycemic agents, hypolipidemic agents, and lenitives for digestive disorders
US6090842A (en) * 1998-03-10 2000-07-18 The Regents Of The University Of California Lipoic acid analogs
US6191162B1 (en) 1998-05-28 2001-02-20 Medical Research Institute Method of reducing serum glucose levels
US20050085498A1 (en) * 1998-05-28 2005-04-21 Byrd Edward A. Oral formulation of lipid soluble thiamine, lipoic acid, creatine derivative, and L-arginine alpha-ketoglutarate
US20040259895A1 (en) * 1998-05-28 2004-12-23 Medical Research Institute Oral formulation of lipid soluble thiamine and lipoic acid
US6905707B2 (en) * 1998-05-28 2005-06-14 Medical Research Institute Controlled release arginine alpha ketoglutarate
US6197340B1 (en) 1998-05-28 2001-03-06 Medical Research Institute Controlled release lipoic acid
US6136339A (en) 1998-08-21 2000-10-24 Gardiner; Paul T. Food supplements and methods comprising lipoic acid and creatine
US6900338B1 (en) * 1998-11-25 2005-05-31 Yissum Research Development Company Of The Hebrew University Of Jerusalem Scavenger compounds
US6573299B1 (en) 1999-09-20 2003-06-03 Advanced Medical Instruments Method and compositions for treatment of the aging eye
DE10045904B4 (de) * 1999-10-01 2007-07-12 Degussa Gmbh alpha-Liponsäure(-Derivate) enthaltende Retardform
EP1216043B1 (de) * 1999-10-01 2003-05-07 Degussa AG Alpha-liponsäure(-derivate)enthaltende retardform
US6664287B2 (en) * 2000-03-15 2003-12-16 Bethesda Pharmaceuticals, Inc. Antioxidants
DK1294353T3 (da) * 2000-06-06 2006-07-10 Basf Ag Anvendelse af en (R) -enantiomer af liponsyre i kosmetiske og dermatologiske sammensætninger
DE10027968A1 (de) * 2000-06-08 2001-12-13 Asta Medica Ag Mittel zur Therapie von Demenzen
US6683110B1 (en) 2001-05-23 2004-01-27 University Of Central Florida Methyl esters of substituted 4-oxo-2-butenoic acid for treatment of tuberculosis
US6649610B1 (en) 2001-05-23 2003-11-18 University Of Central Florida 2-oxo-1, 4-benzoxazine compounds for treatment of tuberculosis
US6686496B1 (en) 2001-06-08 2004-02-03 University Of Central Florida Treatment of myeloma
US6852876B1 (en) 2001-06-08 2005-02-08 University Of Central Florida Treatment of colon cancer
US7049461B1 (en) 2001-06-08 2006-05-23 University Of Central Florida Treatment of leukemia
US6602907B1 (en) 2001-06-08 2003-08-05 University Of Central Florida Treatment of breast cancer
WO2003072052A2 (en) * 2002-02-22 2003-09-04 Albany College Of Pharmacy Methods and compounds useful in inhibiting oxidative and/or free radical damage and in the treatment and prevention of disease
US7030154B2 (en) * 2002-06-07 2006-04-18 Juvenon, Inc. Stability of lipoic acid
DE10229995A1 (de) * 2002-07-03 2004-01-15 Beiersdorf Ag Kosmetische oder dermatologische Zubereitungen mit einem Gehalt an alpha-Liponsäure
US20040133938A1 (en) * 2002-11-19 2004-07-08 Yinghui Dan Use of lipoic acid in plant culture media
DE10318045A1 (de) * 2003-04-17 2004-11-04 Basf Ag Stabile Ammoniumsalze der alpha-Liponsäure, ihre Herstellung und Verwendung
JP4716666B2 (ja) * 2003-05-21 2011-07-06 有限会社オガ リサーチ α−リポ酸含有水性製剤
CN100422134C (zh) * 2004-03-12 2008-10-01 北京天衡药物研究院 新的2-（α-正戊酮基）苯甲酸盐及其制法和用途
US20060213815A1 (en) * 2005-01-28 2006-09-28 Wille John J Hydrocarbon fume suppression by higher vapor pressure temperature oils
WO2006134609A2 (en) * 2005-06-16 2006-12-21 Mmi Corporation Novel anticancer agent, methods for obtaining the same and pharmaceutical compositions thereof
BRPI0621285A2 (pt) * 2006-01-31 2011-12-06 Parsroos Co. método para a preparação de um extrato vegetal e processo de produção de uma composição farmacêutica para estìmulo imunológico e/ou tratamento de infecções por hiv que compreende o referido extrato vegetal
US7282225B1 (en) 2006-09-27 2007-10-16 Occular Technologies, Inc. Composition and methods for improving retinal health
EA014669B1 (ru) * 2009-06-08 2010-12-30 Общество С Ограниченной Ответственностью "Научно-Производственный Центр Белагроген" Препарат на основе интерферона
CN107820422B (zh) * 2015-05-21 2022-02-08 摩纳哥奥夫塔尔米斯公司 包含硫辛酸和类粘液状聚合物的眼用组合物

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA901960A (en) * 1972-06-06 Rossler Richard PROCESS FOR STABILIZING .alpha.-LIPOIC ACID IN PHARMACEUTICAL SOLUTIONS
US2840505A (en) * 1954-04-09 1958-06-24 Du Pont Process of treating animals for metal poisoning with thio-compounds
US2875227A (en) * 1955-05-11 1959-02-24 Merck & Co Inc Ephedrine salts of 7-carboethoxy-3-acetylthioheptanoic acid
US2933430A (en) * 1959-01-22 1960-04-19 Du Pont Lipoic acid compositions
DE1617740B1 (de) * 1967-09-25 1971-11-04 Pfrimmer & Co J Verfahren zum Stabilisieren von Alfa-Liponsäure
DE1668887B2 (de) * 1968-03-15 1976-06-16 Ca-salz der 1,2 -dithia-cyclopentan - 3- valerian saeure gleich (thioctsaeure)
ZA716628B (en) * 1970-10-15 1972-06-28 Richardson Merrell Spa Composition and method for treatment of hepatic disease and mental fatigue
JPS5026516A (it) * 1973-07-07 1975-03-19
US4100150A (en) * 1975-11-04 1978-07-11 G. D. Searle & Co. Stabilization of interferon against mechanical stress using thioctic acid
DE3273597D1 (en) * 1981-11-28 1986-11-06 Sunstar Kk Pharmaceutical composition containing interferon in stable state
EP0127012A3 (en) * 1983-05-30 1987-05-27 Suntory Limited Antimutagenic agent and a method of reducing mutagenicity
CH656382A5 (de) * 1983-10-24 1986-06-30 Sandoz Ag Sulfoxide, verfahren zu ihrer herstellung und ihre verwendung.
JPS60146829A (ja) * 1984-01-05 1985-08-02 Rooto Seiyaku Kk テストステロン５α−リダクタ−ゼ阻害剤
JPS60184011A (ja) * 1984-03-02 1985-09-19 Itaru Yamamoto 免疫調節剤
EP0159519A3 (de) * 1984-03-29 1987-02-04 Asta-Werke Aktiengesellschaft Chemische Fabrik Verwendung von Thioverbindungen zur Verhinderung des durch Cytostatika verursachten Haarausfalls
DE3650130T3 (de) * 1985-03-16 2003-07-24 The Wellcome Foundation Ltd., London Antivirale Nukleoside.
DE3512911A1 (de) * 1985-04-11 1986-10-16 Degussa Ag, 6000 Frankfurt Verfahren zur herstellung von 1,2-dithiolan-3-pentansaeure (thioctsaeure)
DE3615710A1 (de) * 1986-05-09 1987-11-26 Hoechst Ag Zubereitungen fuer die synthese von prostaglandinen und hydroxyfettsaeuren in biologischen systemen
JP2543096B2 (ja) * 1987-09-24 1996-10-16 松下電器産業株式会社 燃焼装置
EP0318891B1 (de) * 1987-12-04 1992-01-02 ASTA Medica Aktiengesellschaft Injizierbare Lösung des Thioctsäuresalzes mit Trometamol und/oder basischen Aminosäuren
DE3840076A1 (de) * 1987-12-04 1989-06-15 Asta Pharma Ag Injizierbare loesung des thioctsaeuresalzes mit trometamol und/oder basischen aminosaeuren
JPH01203336A (ja) * 1988-02-09 1989-08-16 Teikoku Seiyaku Kk 経皮・口腔粘膜適用製剤
EP0382066A3 (de) * 1989-02-09 1992-01-08 ASTA Medica Aktiengesellschaft Verwendung von Dihydroliponsäure als Analgetikum, Antiphlogistikum und/oder Zytoprotektivum
DE4002706A1 (de) * 1989-02-09 1990-08-16 Asta Pharma Ag Arzneimittel enthaltend als wirkstoff dihydroliponsaeure
ES2115589T3 (es) * 1989-11-09 1998-07-01 Asta Medica Ag Medicamento que contiene acido r-alfa-liponico o acido s-alfa-liponico como sustancia activa.
JPH10203336A (ja) * 1997-01-17 1998-08-04 Aisin Seiki Co Ltd アンチスキッド制御装置

Also Published As

Publication number Publication date
DE9017987U1 (de) 1993-12-09
GR1000918B (el) 1993-03-16
EP0427246A3 (en) 1992-06-03
AT500684A1 (de) 2006-02-15
CA2029599A1 (en) 1991-05-10
DE4035456A1 (de) 1991-05-16
SE508601C2 (sv) 1998-10-19
GB2239797A (en) 1991-07-17
SE9003564D0 (sv) 1990-11-08
PT95827B (pt) 1997-11-28
GR1001503B (el) 1994-02-28
IE904035A1 (en) 1991-05-22
BE1005018A3 (fr) 1993-03-23
BE1003834A5 (fr) 1992-06-23
SE9003564L (sv) 1991-06-07
GR900100796A (en) 1992-04-17
ES2029769A6 (es) 1992-09-01
LU87834A1 (de) 1991-05-07
JPH03188021A (ja) 1991-08-16
ATE126053T1 (de) 1995-08-15
DK173585B1 (da) 2001-04-02
US5334612A (en) 1994-08-02
DK267790D0 (da) 1990-11-08
GB2239797B (en) 1994-06-15
CA2029599C (en) 1998-08-11
CH684054A5 (de) 1994-07-15
GB9024252D0 (en) 1990-12-19
DK0427246T3 (da) 1995-11-27
FR2653997B1 (fr) 1995-01-20
IE67874B1 (en) 1996-05-01
DK267790A (da) 1991-05-10
EP0427246A2 (de) 1991-05-15
PT95827A (pt) 1991-09-13
DE59009497D1 (de) 1995-09-14
DK200001239A (da) 2000-08-22
AT500684B1 (de) 2006-10-15
IT9048456A1 (it) 1992-05-08
GR3017695T3 (en) 1996-01-31
DK173752B1 (da) 2001-09-10
NL9002438A (nl) 1991-06-03
ES2076279T3 (es) 1995-11-01
EP0427246B1 (de) 1995-08-09
FR2653997A1 (fr) 1991-05-10
IT1246328B (it) 1994-11-17
AT500684B8 (de) 2006-11-15

Similar Documents

Publication Publication Date Title
PT95343A (pt) Processo para a preparacao de composicoes farmaceuticas contendo doses baixas de um agente anticoagulante oral tal como o warfarin e de um inibidor de plaquetas tal como o acido acetilsalilico,como ingredientes acticovos apropriadas para otratamento e/ou prevencao de doencas cardiacas
IT1246328B (it) Medicamenti contenenti acidi carbossilici contenenti zolfo quali agenti attivi nonche' procedimento per la loro produzione e loro impiego per la lotta ai retrovirus.
ATE188119T1 (de) Heilmittel für wunden und hämorrhoiden
FI842760A0 (fi) Menetelmä terapeuttisesti aktiivisten imidatsoliumyhdisteiden valmistamiseksi
NO171214C (no) Analogifremgangsmaate ved fremstilling av terapeutisk aktive pyridonkarboksylsyrederivater
PT920865E (pt) Utilizacao de ""norastemizole"" para o tratamento de disturbios alergicos
EP0287193A3 (en) Use of nedocromil sodium in the treatment of cystic fibrosis
IT8847794A0 (it) Derivati dell'acido furanuronico, loro preparazione e loro impiego come medicamenti
IL90056A0 (en) Topical pharmaceutical compositions containing 4-quinoline carboxylic acid derivatives
FR2615512B1 (fr) Composes de benzamides substitues pharmacologiquement actifs, compositions pharmaceutiques contenant ces composes, et leur procede de preparation
SE8501518L (sv) Farmaceutiska preparat
IT8620703A0 (it) Derivati dell'acido 4-fenil 4-osso 2-butenoico, loro procedimento di preparazione e loro impiego come prodotti medicinali.
IT1197289B (it) Sale di lisina dell'acido 4-bifenilacetico e sue composizioni oftalmiche
NO852741L (no) Fremgangsmaate for fremstilling av terapeutisk aktive 5,6-dihydro-4h-cyklopenta (b)tiofen-6-karboksylsyre-derivater
ITMI910581A0 (it) Derivati dell'acido 5-fenil-1h-pirazol-4-propionico, loro preparazione e loro impiego come medicamenti
IT1199994B (it) Derivati dell'acido d-2-(6-metossi-2-naftil)-propionico ad attivita'terapeutica,procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT1189216B (it) Derivati dell'acido fenilidrazincar bossilico,loro preparazione e loro impiego come agenti fungicidi
KR840007356A (ko) 나파자트롬을 함유한 약제조성물
IT1200460B (it) Composizioni di farmaci dotae di attivita' antimicrobica e procedimento per la loro preparazione
NO863005D0 (no) Fremgangsmaate for fremstilling av terapeutisk aktive 1,4,5,6,7,8-heksahydro-2-alkyl-4-aryl-5-okso-1,7-naftyridin-3-karboksylsyreesterderivater.
ITMI910133A0 (it) Derivati salini del gliceril fosforil mioinositolo ad attivita' terapeutica procedimento per la loro preparazione e composizioni farmaceutiche che li contengono
IT8249164A0 (it) Picolilamidi sostituite dell'acido 4-idrossi-isoftalico, procedimento per la loro produzione e loro impiego farmaceutico
FR2554441B1 (fr) Derives de fluorene, agent anti-inflammatoires et/ou analgesiques et/ou anti-pyretiques contenant au moins l'un de ces composes en tant qu'ingredient actif et procede de fabrication de ces composes
IT8021053A0 (it) Ammidi dell'acido teofillin-7-acetico, procedimenti per la loro preparazione e relative composizioni farmaceutiche.
IT8748533A0 (it) Te attivi loro impiego e produzione composti propanolici terapeuticamennonche' preparazioni farmaceutiche che li contengono

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19961025